As of mid-2026, the weight loss lineup includes oral GLP-1 options like the Wegovy pill (including a microdosing plan), the Ozempic pill, and Hers own Foundayo pill, plus injection pens, Zepbound vials and KwikPens, and brand-name Ozempic, Mounjaro, and Zepbound
The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
Descriptions of side effects reflect individual responses to GLP1 medications
See our complete injection technique guide for additional tips on reducing discomfort and improving absorption
Staying hydrated, eating small frequent meals, and avoiding high-fat or spicy foods can reduce symptoms